Effects of emodin on the gene expression profiling of human breast carcinoma cells

Cancer Detection and Prevention

Volumn 32, Issue 4, 2009, Pages 286-291

  Huang, Zhiwei ^a,b   Chen, Guichen ^a   Shi, Ping ^a,c  

^a NORTHWEST INSTITUTE OF PLATEAU BIOLOGY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; cDNA microarray; Emodin; Human breast cancer BCap 37 cells; IGF 2; Mitochondrial signaling pathway

Indexed keywords

CALPAIN; CASPASE; COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; CYTOCHROME C; DEATH RECEPTOR; DNA FRAGMENT; EMODIN; GRANZYME; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; DNA FRAGMENTATION; DNA MICROARRAY; FOLLOW UP; GENE DISRUPTION; GENE EXPRESSION PROFILING; GENE INDUCTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; EMODIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; INSULIN-LIKE GROWTH FACTOR II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN KINASE INHIBITORS; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION;

EID: 60749104674     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2008.12.003     Document Type: Article

References (38)

1. Cai J., Xuan Z.R., Wei Y.P., Yang H.B., and Wang H. Effects of perioperative administration of Rhubarb on acute inflammatory response in patients with gastric cancer. Zhong Xi Yi Jie He Xue Bao 3 (2005) 195-198 [in Chinese]
2. Mantani N, Sekiya N, Sakai S, Kogure T, Shimada Y, Terasawa K. Rhubarb use in patients treated with Kampo medicines-a risk for gastric cancer? Yakugaku Zasshi 2002;122:403-5. Available from: http://www.jstage.jst.go.jp/article/yakushi/122/6/122_403/_article/-char/en
3. Cao Y., Xia Q.H., Meng H., and Zhong A.P. Antitumor and synergistic effect of Chinese medicine "bushen huayu jiedu recipe" and chemotherapy on transplanted animal hepatocarcinoma. World J Gastroenterol 11 (2005) 5218-5220
4. Kang S.C., Lee C.M., Choi H., Lee J.H., Oh J.S., Kwak J.H., et al. Evaluation of oriental medicinal herbs for estrogenic and antiproliferative activities. Phytother Res 20 (2006) 1017-1019
5. Zhang L., Lau Y.K., Xia W., Hortobagyi G.N., and Hung M.C. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. Clin Cancer Res 5 (1999) 343-353
6. Yi J., Yang J., Wang Y., Li H., Chen Y., Hu Q., et al. Alteration of subcellular redox equilibrium and the consequent oxidative modification of nuclear factor κB are critical for anticancer cytotoxicity by emodin, a reactive oxygen species-producing agent. Free Radical Bio Med 40 (2006) 2183-2197
7. Su Y.T., Chang H.L., Shyue S.K., and Hsu S.A. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem Pharmacol 70 (2005) 229-241
8. Yi J., Yang J., He R., Gao F., Sang H., Tang X., et al. Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Res 64 (2004) 108-116
9. Chen Y.C., Shen S.C., Lee W.R., Hsu F.L., Lin H.Y., Ko C.H., et al. Emodin induces apoptosis in human promyeleukemic HL60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem Pharmacol 64 (2002) 1713-1724
10. Huang Z., Chen G., and Shi P. Emodin-induced apoptosis in human breast cancer BCap-37 cells through the mitochondrial signaling pathway. Arch Pharm Res 31 (2008) 742-748
11. Kuwano K., Yoshimi M., Maeyama T., Hamada N., Yamada M., and Nakanishi Y. Apoptosis signaling pathways in lung diseases. Med Chem 1 (2005) 49-56
12. Schena M., Shalon D., and Davis R.W. Brown PO Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
13. Khan J., Bittner M.L., Chen Y., Meltzer P.S., and Trent J.M. DNA microarray technology: the anticipated impact on the study of human disease. Biochim Biophys Acta 1423 (1999) 17-28
14. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-delta delta CT method. Methods 25 (2001) 402-408
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
16. Ping S., Wang S., Zhang J., and Peng X. Effects of all-trans-retinoic acid on mRNA binding protein p62 in human gastric cancer cells. Int J Biochem Cell Biol 37 (2005) 616-627
17. Sun Y. p53 and its downstream proteins as molecular targets of cancer. Mol Carcinogen 45 (2006) 409-415
18. Kumar A., Dhawan S., and Aggarwal B.B. Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 17 (1998) 913-918
19. Lee J., Jung E., Lee J., Huh S., Hwang C.H., Lee H.Y., et al. Emodin inhibits TNF alpha-induced MMP-1 expression through suppression of activator protein-1 (AP-1). Life Sci 79 (2006) 2480-2485
20. Kitano A., Saika S., Yamanaka O., Ikeda K., Okada Y., Shirai K., et al. Emodin suppression of ocular surface inflammatory reaction. Invest Ophthalmol Vis Sci 48 (2007) 5013-5022
21. Lee C.M., and Reddy E.P. The v-myc oncogene. Oncogene 18 (1999) 2997-3003
22. Liu G., Ye R., and Tan Z. Effect of emodin on fibroblasts in lupus nephritis. Zhongguo Zhong Xi Yi Jie He Za Zhi 20 (2000) 196-198 [in Chinese]
23. Huang L.Y., Hu J.D., Chen X.J., Zhu L.F., and Hu H.L. Effects of emodin on the proliferation inhibition and apoptosis induction in HL-60 cells and the involvement of c-myc gene. Zhonghua Xue Ye Xue Za Zhi 26 (2005) 348-351 [in Chinese]
24. Chen Y.Y., Zheng H.Y., Hu J.D., Zheng Z.H., Zheng J., Lian X.L., et al. Inhibitory effects of emodin on drug-resistant HL-60/ADR cell proliferation and its induction of apoptosis. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15 (2007) 955-960 [in Chinese]
25. Bech-Otschir D., Seeger M., and Dubiel W. The COP9 signalosome: at the interface between signal transduction and ubiquitindependent proteolysis. J Cell Sci 115 (2002) 467-473
26. Bech-Otschir D., Kraft R., Huang X., Henklein P., Kapelari B., Pollmann C., et al. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 20 (2001) 1630-1639
27. Seeger M., Kraft R., Ferrell K., Bech-Otschir D., Dumdey R., Schade R., et al. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J 12 (1998) 469-478
28. Naumann M., Bech-Otschir D., Huang X., Ferrell K., and Dubiel W. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J Biol Chem 274 (1999) 35297-35300
29. Füllbeck M., Huang X., Dumdey R., Frommel C., Dubiel W., and Preissner R. Novel curcumin- and emodin-related compounds identified by in silico 2D/3D conformer screening induce apoptosis in tumor cells. BMC Cancer 5 (2005) 97-110
30. Kuo P.L., Lin T.C., and Lin C.C. The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci 71 (2002) 1879-1892
31. Tsao Y.P., Li S.F., Liu J.C., and Chen S.L. Apoptosis is induced in aging SV40 T antigen-transformed human fibroblasts through p53- and p21CIP1/WAF1-independent pathways. Cancer Lett 133 (1998) 77-82
32. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
33. Schuler M., Bossy-Wetzel E., Goldstein J.C., and Fitzgerald P. Green DR. p53 induces apoptosis by caspase activation through mitochondrial cytochrome C release. J Biol Chem 275 (2000) 7337-7342
34. Ain R., Canham L.N., and Soares M.J. Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor 2 and the Akt signaling pathway. J Endocrinol 185 (2005) 253-263
35. O'Dell S.D., and Day I.N.M. Insulin-like growth factor II (IGF2). Int J Biochem Cell Biol 30 (1998) 767-771
36. Christofori G., Naik P., and Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369 (1994) 414-418
37. Lund P., Schubert D., Niketeghad F., and Schirmacher P. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor 2. Cancer Lett 206 (2004) 85-96
38. Shindler K.S., Yunker A.M.R., Cahn R., Zha J., Korsmeyer S.J., and Roth K.A. Trophic support promotes survival of Bcl-x-deficient telencephalic cells in vitro. Cell Death Differ 5 (1998) 901-910